Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchial arterial infusion plus oral icotinib for advanced non-small cell lung cancer
ChiCTR-OPN-15006795Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of icotinib in non-small cell lung cancer (NSCLC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Tumor volume. Started Jul 2015; status: recruiting.
02
Drugs
icotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-OPN-15006795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006795.